Nonalcoholic steatohepatitis (NASH) is a chronic liver condition characterized by inflammation and fat accumulation in the liver, which can progress to liver fibrosis, cirrhosis, and even liver cancer. As the global prevalence of NASH rises, there is a growing demand for effective treatmen